PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
20-Feb-2020 ImmunoPrecise Launches Coronavirus Vaccine and Therapeutic Antibody Program ImmunoPrecise Antibodies Ltd.
20-Feb-2020 Vifor Pharma and Fresenius Kabi create joint venture in China for i.v. iron portfolio Vifor Pharma Group
20-Feb-2020 Polyphor announces progress of the Phase III immuno-oncology program with balixafortide. Renewed strategy in advancing antibiotics and oncology research and pipeline Polyphor
20-Feb-2020 Montis Biosciences launched with €8,4 million seed financing and a novel approach to immuno-oncology Montis Biosciences
20-Feb-2020 Galderma Announces New England Journal of Medicine Publication from Phase 2 Study of Investigational Therapy Nemolizumab in Patients with Moderate to Severe Prurigo Nodularis Galderma
20-Feb-2020 IDT launches xGen Prism DNA Library Prep Kit Integrated DNA Technologies, Inc.
20-Feb-2020 Medigene AG: Medigene participates at upcoming conferences Medigene AG
20-Feb-2020 Global Biosimilars Market to Reach ~US$ 21.1 bn by 2027, Role in Reducing Cost of Cancer Treatment Key to Growth: Transparency Market Research Transparency Market Research
19-Feb-2020 Cantargia Has Completed a Directed Share Issue of Approximately SEK 410 Million Cantargia AB
19-Feb-2020 Cantargia Announces Intention of a Directed Share Issue Cantargia AB
19-Feb-2020 Pfizer’s Vyndaqel set to achieve blockbuster status in 2021 with new EU approval for expanded use in ATTR-CM Pfizer
19-Feb-2020 Driven by its successful debut, the Second Annual International HealthTech Innovation Days will take place in Paris on June 22nd & 23rd France Biotech
19-Feb-2020 Cegedim launches new Clinical Decision Support App to support safe and effective care Cegedim UK
19-Feb-2020 Lundbeck increases its share capital by 11,497 shares (0.0058 % of outstanding shares) as a result of exercise of employee warrants Lundbeck
19-Feb-2020 Orgenesis announces collaboration with the John Hopkins University for the development and processing of cell and gene based clinical therapeutics Orgenesis
19-Feb-2020 Immutep reports positive TACTI-002 data Immutep
19-Feb-2020 Orgenesis announces collaboration with the John Hopkins University for the development and processing of cell and gene based clinical therapeutics Orgenesis
19-Feb-2020 European Commission Grants Marketing Authorisation for VYNDAQEL®  (tafamidis), the First Treatment in the EU for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Pfizer
19-Feb-2020 SEARCHING FOR BIOMARKERS AND THERPEUTIC AGENTS AGAINST BREAST CANCER Karl Landsteiner University
19-Feb-2020 Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2019 on February 26, 2020 Viking Therapeutics, Inc.